Literature DB >> 20644414

Extended long-term (> 5 years) outcome of cerebrospinal fluid shunting in idiopathic normal pressure hydrocephalus.

Mohammad Javad Mirzayan1, Goetz Luetjens, Jan Juliaan Borremans, Jens Peter Regel, Joachim Kurt Krauss.   

Abstract

BACKGROUND: Shunt surgery has been established as the only durable and effective treatment for idiopathic normal pressure hydrocephalus.
OBJECTIVE: We evaluated the "extended" long-term follow-up (> 5 years) in a prospective study cohort who underwent shunting between 1990 and 1995. A secondary objective was to determine the cause of death in these patients.
METHODS: Fifty-one patients were included after confirmation of the diagnosis by extensive clinical and diagnostic investigations. Surgery included ventriculoatrial or ventriculoperitoneal shunting with differential pressure valves in the majority of patients. For each of the cardinal symptoms, postoperative outcome was assessed separately with the Krauss Improvement Index, yielding a value between 0 (no benefit) and 1 (optimal benefit) for the overall outcome.
RESULTS: Mean age at surgery was 70.2 years (range, 50-87 years). Thirty patients were women, and 21 were men. Short-term (18.8 +/- 16.6 months) follow-up was available for 50 patients. The Krauss Improvement Index was 0.66 +/- 0.28. Long-term (80.9 +/- 51.6 months) follow-up was available for 34 patients. The Krauss Improvement Index was 0.64 +/-0.33. Twenty-nine patients died during the long-term follow-up at a mean age of 75.8 years (range, 55-95 years). The major causes of death were cardiovascular disorders: cardiac failure (n = 7) and cerebral ischemia (n = 12). Other causes were pneumonia (n = 2), acute respiratory distress syndrome (n = 1), pulmonary embolism (n = 1), cancer (n = 2), renal failure (n = 1), and unknown (n = 3). There was no shunt-related mortality.
CONCLUSION: Idiopathic normal pressure hydrocephalus patients may benefit from shunting over the long term when rigorous selection criteria are applied. Shunt-related mortality is negligible. The main cause of death is vascular comorbidity.

Entities:  

Mesh:

Year:  2010        PMID: 20644414     DOI: 10.1227/01.NEU.0000371972.74630.EC

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  10 in total

Review 1.  Normal pressure hydrocephalus-an overview of pathophysiological mechanisms and diagnostic procedures.

Authors:  Petr Skalický; Arnošt Mládek; Aleš Vlasák; Patricia De Lacy; Vladimír Beneš; Ondřej Bradáč
Journal:  Neurosurg Rev       Date:  2019-11-08       Impact factor: 3.042

2.  Intraventricular infusion test accuracy in predicting short- and long-term outcome of iNPH patients: a 10-year update of a three-decade experience at a single institution.

Authors:  Gianluca Trevisi; Francesco Signorelli; Chiara de Waure; Vito Stifano; Cosimo Sturdà; Alessandro Rapisarda; Angelo Pompucci; Annunziato Mangiola; Carmelo Anile
Journal:  Neurosurg Rev       Date:  2021-02-15       Impact factor: 3.042

3.  Long term follow-up of shunted idiopathic normal pressure hydrocephalus patients: a single center experience.

Authors:  Matheus Fernandes de Oliveira; A A Boa Sorte; D L Emerenciano; J M Rotta; G A S Mendes; F C G Pinto
Journal:  Acta Neurol Belg       Date:  2020-11-02       Impact factor: 2.396

4.  External lumbar drain: A pragmatic test for prediction of shunt outcomes in idiopathic normal pressure hydrocephalus.

Authors:  Silky Chotai; Ricky Medel; Nabeel A Herial; Azedine Medhkour
Journal:  Surg Neurol Int       Date:  2014-01-27

5.  Long-term effects of complications and vascular comorbidity in idiopathic normal pressure hydrocephalus: a quality registry study.

Authors:  Kerstin Andrén; Carsten Wikkelsö; Nina Sundström; Simon Agerskov; Hanna Israelsson; Katarina Laurell; Per Hellström; Mats Tullberg
Journal:  J Neurol       Date:  2017-11-29       Impact factor: 4.849

6.  Magnetic resonance parkinsonism indices and interpeduncular angle in idiopathic normal pressure hydrocephalus and progressive supranuclear palsy.

Authors:  Lorenzo Ugga; Renato Cuocolo; Sirio Cocozza; Giuseppe Pontillo; Andrea Elefante; Mario Quarantelli; Caterina Vicidomini; Maria Francesca De Pandis; Giovanna De Michele; Alessandra D'Amico; Oreste de Divitiis; Arturo Brunetti
Journal:  Neuroradiology       Date:  2020-07-24       Impact factor: 2.804

Review 7.  A Review of Clinical Outcomes for Gait and Other Variables in the Surgical Treatment of Idiopathic Normal Pressure Hydrocephalus.

Authors:  Richard Shaw; Neil Mahant; Erica Jacobson; Brian Owler
Journal:  Mov Disord Clin Pract       Date:  2016-02-18

8.  Challenges in cerebrospinal fluid shunting in patients with glioblastoma.

Authors:  Bujung Hong; Manolis Polemikos; Hans E Heissler; Christian Hartmann; Makoto Nakamura; Joachim K Krauss
Journal:  Fluids Barriers CNS       Date:  2018-06-04

Review 9.  Current Updates on Idiopathic Normal Pressure Hydrocephalus.

Authors:  Boon Seng Liew; Kiyoshi Takagi; Yoko Kato; Shyam Duvuru; Sengottuvel Thanapal; Balamurugan Mangaleswaran
Journal:  Asian J Neurosurg       Date:  2019 Jul-Sep

10.  Survival in treated idiopathic normal pressure hydrocephalus.

Authors:  Kerstin Andrén; Carsten Wikkelsø; Nina Sundström; Hanna Israelsson; Simon Agerskov; Katarina Laurell; Per Hellström; Mats Tullberg
Journal:  J Neurol       Date:  2019-11-11       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.